Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...

Abstract: Drug-drug interaction (DDI) can trigger many adverse effects in patients and has emerged as a threat to medicine and public health. Therefore, it is important to predict potential drug ...

Relay Therapeutics, Inc. leads with RLY-2608, an allosteric PI3Kα inhibitor showing superior safety & efficacy. Learn more ...

A new scientific report reveals that the protein aggregates associated with Parkinson’s disease are not inert clumps of ...

Novak Djokovic's former coach Boris Becker objected to players complaining about the ATP schedule. The recently held Shanghai Masters also noted the absence of a few seeded players, most of whom cited ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...

In human cells, there are about 20,000 genes on a two-meter DNA strand—finely coiled up in a nucleus about 10 micrometers in diameter. By comparison, this corresponds to a 40-kilometer thread packed ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Water-based pharmacophore modeling is an emerging approach in inhibitor design that ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Researchers at the Massachusetts Institute of Technology and Recursion Pharmaceuticals Inc. have released an open-source AI model that can predict the binding strength of small molecules as well as ...

In traditional drug and agriculture chemical research, scientists usually test one factor at a time—first checking if a compound works, then later testing for safety and stability. This step-by-step ...

Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. MIT and Recursion have released Boltz-2, the first ...